跳至主要内容
临床试验/NCT02090686
NCT02090686已完成不适用

Efficacy of Pulsatile Cupping in Patients With Chronic Low Back Pain - a Randomized Controlled Study.

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Intensity of pain on visual analogues scale

研究概览

简要总结

The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female, 18-65 years
  • •Chronic low back pain (disease duration > 3 months)
  • •Pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • •Only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • •Undersigned informed consent form

排除标准

  • •Use of anticoagulants (Phenprocoumon, Heparin)
  • •Coagulopathy
  • •Cupping in the last 6 weeks
  • •Other CAM therapies in the last 12 weeks (e.g. acupuncture)
  • •Physical therapy in the last 12 weeks (e.g. massage, osteopathy)
  • •participation in another study in the last 3 months
  • •Paracetamol allergy or intolerance
  • •Pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • •Known renal and / or hepatic diseases
  • •Intake of central nervous system-acting analgesics in the last 6 weeks
  • •Applying for early retirement due to low back pain
  • •Severe disease that does not allow participation
  • •No undersigned informed consent form

研究组 & 干预措施

Pulsatile Cupping

Active Comparator

干预措施: Pulsatile Cupping (Device)

No Intervention

No Intervention

Waiting list

Minimal Cupping

Active Comparator

干预措施: Minimal Cupping (Device)

结局指标

主要结局

Intensity of pain on visual analogues scale

时间窗: 4 weeks

次要结局

  • Intensity of pain on visual analogue scale(12 weeks)
  • Back function - FFbH-R-Questionnaire(4 weeks, 12 weeks)
  • Quality of Life - SF 36(4 weeks, 12 weeks)
  • Assessment of perceived effect on Likert Scale(4 weeks, 12 weeks)
  • Intake of paracetamol(4 weeks)
  • Adverse events(week 1- 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benno Brinkhaus

Prof.

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验